Literature DB >> 22210475

Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin.

P H Dejonckere1, K J Neumann, M B J Moerman, J P Martens, A Giordano, C Manfredi.   

Abstract

Spasmodic dysphonia voices form, in the same way as substitution voices, a particular category of dysphonia that seems not suited for a standardized basic multidimensional assessment protocol, like the one proposed by the European Laryngological Society. Thirty-three exhaustive analyses were performed on voices of 19 patients diagnosed with adductor spasmodic dysphonia (SD), before and after treatment with Botulinum toxin. The speech material consisted of 40 short sentences phonetically selected for constant voicing. Seven perceptual parameters (traditional and dedicated) were blindly rated by a panel of experienced clinicians. Nine acoustic measures (mainly based on voicing evidence and periodicity) were achieved by a special analysis program suited for strongly irregular signals and validated with synthesized deviant voices. Patients also filled in a VHI-questionnaire. Significant improvement is shown by all three approaches. The traditional GRB perceptual parameters appear to be adequate for these patients. Conversely, the special acoustic analysis program is successful in objectivating the improved regularity of vocal fold vibration: the basic jitter remains the most valuable parameter, when reliably quantified. The VHI is well suited for the voice-related quality of life. Nevertheless, when considering pre-therapy and post-therapy changes, the current study illustrates a complete lack of correlation between the perceptual, acoustic, and self-assessment dimensions. Assessment of SD-voices needs to be tridimensional.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210475      PMCID: PMC3311985          DOI: 10.1007/s00405-011-1890-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

1.  A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS).

Authors:  P H Dejonckere; P Bradley; P Clemente; G Cornut; L Crevier-Buchman; G Friedrich; P Van De Heyning; M Remacle; V Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-02       Impact factor: 2.503

2.  Documentation of progress in voice therapy: perceptual, acoustic, and laryngostroboscopic findings pretherapy and posttherapy.

Authors:  R Speyer; G H Wieneke; P H Dejonckere
Journal:  J Voice       Date:  2004-09       Impact factor: 2.009

3.  Pitch and voiced/unvoiced determination with an auditory model.

Authors:  L M Van Immerseel; J P Martens
Journal:  J Acoust Soc Am       Date:  1992-06       Impact factor: 1.840

4.  Perceptual analyses of spasmodic dysphonia before and after treatment.

Authors:  Michael P Cannito; Gayle E Woodson; Thomas Murry; Brenda Bender
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-12

5.  Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.

Authors:  M S Benninger; G Gardner; C Grywalski
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-09

6.  Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes.

Authors:  Daniel Novakovic; Heather H Waters; Joanna B D'Elia; Andrew Blitzer
Journal:  Laryngoscope       Date:  2011-02-04       Impact factor: 3.325

7.  Voice in early glottic cancer compared to benign voice pathology.

Authors:  C D L Van Gogh; H F Mahieu; D J Kuik; R N P M Rinkel; J A Langendijk; I M Verdonck-de Leeuw
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-04-25       Impact factor: 2.503

8.  Objective evaluation of the quality of substitution voices.

Authors:  Mieke Moerman; Glenn Pieters; Jean-Pierre Martens; Marie-Jeanne Van der Borgt; Phillippe Dejonckere
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-15       Impact factor: 2.503

Review 9.  Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.

Authors:  Christopher Watts; Chad Nye; Renata Whurr
Journal:  Clin Rehabil       Date:  2006-02       Impact factor: 3.477

10.  The voice handicap index as a tool for assessment of the biopsychosocial impact of voice problems.

Authors:  K Maertens; F I C R S de Jong
Journal:  B-ENT       Date:  2007       Impact factor: 0.082

View more
  2 in total

1.  A Measure of the Auditory-perceptual Quality of Strain from Electroglottographic Analysis of Continuous Dysphonic Speech: Application to Adductor Spasmodic Dysphonia.

Authors:  Keerthan Somanath; Ted Mau
Journal:  J Voice       Date:  2015-12-28       Impact factor: 2.009

2.  Adductor focal laryngeal Dystonia: correlation between clinicians' ratings and subjects' perception of Dysphonia.

Authors:  Celia Faye Stewart; Catherine F Sinclair; Irene F Kling; Beverly E Diamond; Andrew Blitzer
Journal:  J Clin Mov Disord       Date:  2017-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.